179 related articles for article (PubMed ID: 24322039)
21. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
22. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases.
Wolberink EA; Pasch MC; Zeiler M; van Erp PE; Gerritsen MJ
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):985-9. PubMed ID: 22759209
[TBL] [Abstract][Full Text] [Related]
23. Histopathological and clinical-progressive profile of skin carcinomas: study on 1688 cases.
Pătraşcu V; Stoica LE; Georgescu CV; Pătru E
Rom J Morphol Embryol; 2010; 51(1):171-80. PubMed ID: 20191140
[TBL] [Abstract][Full Text] [Related]
24. Axillary basal cell carcinoma.
LeSueur BW; DiCaudo DJ; Connolly SM
Dermatol Surg; 2003 Nov; 29(11):1105-8. PubMed ID: 14641334
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
26. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
27. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
29. [Basal cell carcinoma of the scalp after radiation therapy for tinea capitis: 33 patients].
Mseddi M; Bouassida S; Marrekchi S; Khemakhem M; Gargouri N; Turki H; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):270-3. PubMed ID: 15450522
[TBL] [Abstract][Full Text] [Related]
30. [Clinico-epidemiologic characteristics of superficial multiple basal cell carcinoma at the Dermatovenereology Clinic in Novi Sad 1986-1996].
Stojanović S; Poljacki M; Preveden R
Med Pregl; 1999; 52(1-2):62-5. PubMed ID: 10352507
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical FHIT expression still exists in early lesions of basal cell carcinoma.
Kiyici H; Bilezikçi B; Ozen O; Demirhan B
Pathol Res Pract; 2010 Jul; 206(7):445-9. PubMed ID: 20399571
[TBL] [Abstract][Full Text] [Related]
32. The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy.
Bertheim U; Hofer PA; Engström-Laurent A; Hellström S
Br J Plast Surg; 2004 Jul; 57(5):429-39. PubMed ID: 15191824
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
36. BerEP4-negative basal cell carcinoma on the palm: case report and review of the literature.
Mleczko A; Franke I; Pokrywka A; Gollnick H; Leverkus M
J Dtsch Dermatol Ges; 2011 Feb; 9(2):140-3. PubMed ID: 20629842
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma.
Lallas A; Tzellos T; Kyrgidis A; Apalla Z; Zalaudek I; Karatolias A; Ferrara G; Piana S; Longo C; Moscarella E; Stratigos A; Argenziano G
J Am Acad Dermatol; 2014 Feb; 70(2):303-11. PubMed ID: 24268311
[TBL] [Abstract][Full Text] [Related]
38. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
Yap FB
Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
[TBL] [Abstract][Full Text] [Related]
40. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
